Source: Carcinogenesis. Unidade: FCF
Subjects: MELANOMA ANIMAL, CARCINOGÊNESE ANIMAL
ABNT
ESPÍNDOLA, Roseli de Moura et al. Geranylgeraniol and beta-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-'kappa'B activation. Carcinogenesis, v. 26, n. 6, p. 1091-1099, 2005Tradução . . Disponível em: https://doi.org/10.1093/carcin/bgi047. Acesso em: 19 out. 2024.APA
Espíndola, R. de M., Mazzantini, R. P., Ong, T. P., Conti, A. de, Heidor, R., & Moreno, F. S. (2005). Geranylgeraniol and beta-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-'kappa'B activation. Carcinogenesis, 26( 6), 1091-1099. doi:10.1093/carcin/bgi047NLM
Espíndola R de M, Mazzantini RP, Ong TP, Conti A de, Heidor R, Moreno FS. Geranylgeraniol and beta-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-'kappa'B activation [Internet]. Carcinogenesis. 2005 ; 26( 6): 1091-1099.[citado 2024 out. 19 ] Available from: https://doi.org/10.1093/carcin/bgi047Vancouver
Espíndola R de M, Mazzantini RP, Ong TP, Conti A de, Heidor R, Moreno FS. Geranylgeraniol and beta-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-'kappa'B activation [Internet]. Carcinogenesis. 2005 ; 26( 6): 1091-1099.[citado 2024 out. 19 ] Available from: https://doi.org/10.1093/carcin/bgi047